Connelly Robert 4
4 · Elicio Therapeutics, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Connelly Robert
DirectorCEO, President and Director
Transactions
- Award
Stock Option (right to buy)
2024-02-01+225,137→ 225,137 totalExercise: $4.50Exp: 2034-02-01→ Common Stock (225,137 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.